Atypical variant guillain-barré syndrome: case report assisted in the university hospital of manaus-am
DOI:
https://doi.org/10.60104/revhugv9983Keywords:
Guillain-Barre Syndrome - Paraparesis - MyelitisAbstract
The Guillain-Barre syndrome (GBS) is a self-limiting acute polyradiculoneuritis, an increase of up to two months, secondary to bacterial or viral infection or vaccination, whose pathology shows demyelinating lesion or, more rarely, axon, the nerve roots and peripheral nerves in any topography, since cranial nerves to the lumbosacral spinal cord. The classic form is characterized by tetraparesia, up arreflexia, often associated with sensory and autonomic dysfunction symptoms, including involving the diaphragm. The albuminocytologic dissociation found in cerebrospinal fluid confirms the diagnosis and is present in 90% of cases. The treatment consists of multidisciplinary support and, for some patients, intravenous immunoglobulin or plasmapheresis. This report aims to describe a patient who was hospitalized at Hospital Universitário Getúlio Vargas (HUGV), who presented GBS with unusual clinical consisting of urinary retention, paraparesis crural, painful anesthesia in the lower limbs, and hipopalestesia below vertebra (T6), simulating spinal cord injury, with protein-cytological dissociation without changes in imaging, which showed partial improvement after receiving intravenous immunoglobulin.
Downloads
References
2. Dimachkie MM, Barohn RJ. Guillain-Barré Syndrome and Variants. Neurol Clin. 2013 May; 31(2): 491–510.
3. Lestayo-O’Farrill Z, Hernández-Cáceres JL. Análisis del comportamiento del síndrome de Guillain-Barré. Consensos y discrepancias. Rev Neurol 2008; 46 (4): 230-237.
4. Seneviratne U. Guillain-Barré syndrome. Postgrad Med J 2000; 76:774–782.
5. Van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, Van Doorn PA. Guillain–Barré syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10, 469–482 (2014).
6. Dimachkie MM, Saperstein DS. Acquired Immune Demyelinating Neuropathies. Continuum (Minneap Minn) 2014;20(5):1241–1260.
7. Hughes RA, Wijdicks EF, Benson E, et al. Supportive care for patients with GuillainBarré syndrome. Arch Neurol 2005;62:1194–1198. (1- 1,).
8. Van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008;7:939–950.
9. Van den Berg B, Fokke C, Drenthen J, van Doorn PA, Jacobs BC. Paraparetic Guillain-Barré syndrome. Neurology. 2014 Jun 3;82(22):1984.
10. Takahide N, Norito K, Nortina S, Kei F, et al. Paraparetic Guillain-Barré syndrome: Extending the axonal spectrum. Neurology and Clinical Neuroscience. 2013 nov 1 (6) 224-226.
